Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AIIM Trial: Protecting Kidney Function After Transplantation Using Augmented Intelligence Based Immunosuppression Dosing

NCT05432765 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT05432765
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05432765 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AIIM Trial: Protecting Kidney Function After Transplantation Using Augmented Intelligence Based Immunosuppression Dosing
Lead sponsor
University of Florida
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 31, 2026
Completion date
January 1, 2031
Enrollment
34 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant rejection